Understanding Opioids: From Medical Use to Public Health Crisis

Last updated 23 hours ago ago. Our resources are updated regularly but please keep in mind that links, programs, policies, and contact information do change.

Opioids are powerful drugs that interact with the human body to produce pain relief and other effects. Sometimes called narcotics, this category includes both legal prescription medications and illegal drugs like heroin.

Their defining characteristic is their dual nature. They rank among the most effective pain relievers in medicine, yet they carry a high potential for misuse, addiction, and overdose.

According to NIDA, opioids are a class of natural, semi-synthetic, and synthetic substances used primarily for treating pain.

Three Types of Opioids

The journey of opioids begins in one of two places: a poppy field or a laboratory. This distinction forms the basis of how experts classify these drugs.

Natural Opioids (Opiates)

These substances come directly from the opium poppy plant, Papaver somniferum. The term “opiate” specifically refers to these naturally occurring compounds.

Key examples include morphine and codeine, which have been used for centuries as pain relievers. The DEA notes that opium has been harvested from poppies for thousands of years.

Semi-Synthetic Opioids

These drugs are created in laboratories using natural opiates as starting material. Common prescription medications fall into this category, including:

• Hydrocodone (found in Vicodin®)
• Oxycodone (found in OxyContin® and Percocet®)
• Heroin (synthesized from morphine)

The illicit drug heroin belongs to this category because it’s synthesized from morphine in clandestine laboratories.

Fully Synthetic Opioids

These are created entirely in laboratories without plant-based ingredients. They’re designed to mimic natural opiates by acting on the same brain receptors.

This group includes medically prescribed drugs like:

• Fentanyl
• Methadone
• Tramadol

The ability to create synthetic opioids without poppy cultivation has fundamentally changed illicit drug manufacturing, fueling the most recent phase of the opioid epidemic.

Medical Uses

Healthcare providers prescribe opioids for managing moderate to severe pain. The Mayo Clinic identifies common scenarios that include:

• Post-surgical pain following major operations
• Severe trauma after serious accidents or injuries
• Procedural pain during certain medical procedures
• Cancer-related pain for patients with advanced disease

The most commonly prescribed opioids include oxycodone, hydrocodone, and morphine. Fentanyl is typically reserved for operating rooms or for managing severe pain in patients already tolerant to other opioids.

Historical Context and Regulation

Opioid use for pain relief dates back thousands of years, long before modern anesthesia. Opium served as a foundational pain reliever in ancient civilizations.

The U.S. government’s role in controlling narcotics began in earnest during the early 20th century.

Early Federal Control

1906 Pure Food and Drug Act: This landmark law was the first major federal legislation regulating drug contents and labeling. It prevented the sale of “adulterated or misbranded or poisonous” medicines.

1914 Harrison Narcotics Tax Act: This pivotal law reshaped opioid access in America. Framed as a tax law, it required anyone importing, manufacturing, or distributing opium or cocaine to register with the federal government and pay a tax.

The act exempted physicians acting “in the course of professional practice.” However, Supreme Court rulings later interpreted this to mean prescribing narcotics simply to maintain addiction wasn’t legitimate medical practice. This effectively criminalized addiction maintenance.

1924 Heroin Act: Congress prohibited the manufacture, importation, and possession of heroin for any purpose, including medical use.

1938 Food, Drug, and Cosmetic Act: This act strengthened federal oversight by mandating manufacturers prove drug safety to the FDA before public sale.

Modern Framework

1970 Controlled Substances Act (CSA): This monumental legislation created a single, unified legal framework for regulating drugs with abuse potential. It established the five-schedule system for classifying drugs based on medical use, abuse potential, and dependence risk.

1973 Creation of the DEA: The Drug Enforcement Administration was formed to enforce the Controlled Substances Act, becoming the lead federal agency for combating drug trafficking.

Recent Crisis Response

2000 Drug Addiction Treatment Act (DATA 2000): This act allowed qualified physicians with special waivers to prescribe buprenorphine for opioid use disorder in private office settings, expanding treatment beyond methadone clinics.

2016 Comprehensive Addiction and Recovery Act (CARA): This bipartisan legislation expanded buprenorphine prescribing to qualified Nurse Practitioners and Physician Assistants.

How Opioids Work in the Body

Understanding opioids’ benefits and dangers requires examining how they interact with the body’s complex systems. Opioids work by hijacking systems our bodies naturally use to control pain and experience pleasure.

The Receptor System

Opioids function by binding to specific proteins called opioid receptors on nerve cell surfaces. These receptors exist throughout the brain, spinal cord, and organs like the gut.

Three main types of opioid receptors exist: mu (μ), delta (δ), and kappa (κ). Most opioids used for pain relief and those associated with addiction—morphine, heroin, and fentanyl—primarily activate the mu-opioid receptor.

Pain Blocking Mechanism

When opioid molecules bind to receptors, they act as inhibitors, dampening pain signal transmission. This happens in two main ways:

Presynaptically: Reduces neurotransmitter release that carries pain messages between nerve cells.

Postsynaptically: Makes receiving nerve cells’ internal electrical charge more negative, making them harder to fire and pass pain signals along.

This blocking action occurs in key central nervous system areas known as the “pain pathway,” including the spinal cord and brainstem. It effectively turns down pain sensations before they reach conscious awareness.

The Reward Pathway

Opioids also affect brain parts regulating emotion and reward, particularly the limbic system. When opioids activate receptors in this “reward pathway,” they trigger dopamine release.

Dopamine produces feelings of pleasure, relaxation, and euphoria—the “high.” Our brains naturally repeat behaviors causing pleasurable dopamine release, which explains why opioids are powerfully reinforcing and have high addiction potential.

Dangerous Side Effects

The same mechanism producing pain relief and euphoria causes the most dangerous side effects. The brainstem, rich in opioid receptors, controls essential life functions like breathing and heart rate.

When opioids activate these receptors, they depress these functions, causing slow, shallow breathing called respiratory depression. At high doses, this can be fatal when breathing stops completely, depriving the brain of oxygen and leading to coma and death.

Other common side effects include drowsiness, confusion, nausea, and severe constipation.

Long-Term Brain Changes

With continued use, the brain adapts to constant opioid presence through neuroplasticity—long-lasting changes to brain structure and chemical function. The brain may reduce natural pain-relieving chemical production and decrease opioid receptor sensitivity or numbers.

These adaptations form the biological basis for tolerance, physical dependence, and addiction. The drug essentially rewires brain priorities, making drug pursuit more important than other previously rewarding activities.

Medical Use Risks and Benefits

When used appropriately under medical supervision, opioids provide vital pain management for specific severe pain types. However, their medicinal power matches their harm potential.

Appropriate Medical Scenarios

Healthcare providers may prescribe opioids for short-term management of acute, severe pain in situations like:

• Post-surgical pain following major operations
• Severe trauma after serious accidents or injuries
• Procedural pain during certain medical procedures like colonoscopies
• Cancer-related pain for advanced cancer patients

Even Prescribed Use Carries Risks

Even when taken exactly as prescribed, opioids present various risks and side effects. Common side effects include drowsiness, mental fog, nausea, and constipation.

More serious risks are always present. Sedative effects can impair judgment and slow reaction times. At higher doses, or when combined with other central nervous system depressants like alcohol or benzodiazepines, life-threatening respiratory depression risk increases dramatically.

Anyone taking opioids regularly for extended periods will develop tolerance and physical dependence—predictable physiological responses to the medication.

Key Terms: Tolerance, Dependence, Addiction, and Overdose

Public conversation about opioids often suffers from confusion over several key terms. Understanding the medical meanings of tolerance, dependence, addiction, and overdose is crucial for reducing stigma and developing effective policy.

Tolerance

This is a physiological state where the body adapts to a drug, reducing response over time. A person experiencing tolerance needs higher or more frequent opioid doses to achieve the same pain relief or euphoria they initially felt.

Tolerance is normal and expected with long-term opioid use, even when taken as prescribed.

Physical Dependence

This adaptation state means the body’s nerve cells require opioid presence to function “normally.” If the drug is suddenly stopped or significantly reduced, the person experiences unpleasant physical and psychological withdrawal symptoms.

These can feel like severe flu and include muscle aches, nausea, vomiting, diarrhea, and intense anxiety. Like tolerance, physical dependence is a predictable consequence of repeated opioid exposure and isn’t addiction by itself.

Addiction (Opioid Use Disorder)

Addiction, clinically diagnosed as Opioid Use Disorder (OUD), is a chronic, relapsing brain disease fundamentally different from tolerance and dependence.

OUD involves problematic opioid use patterns characterized by compulsive drug-seeking and continued use despite harmful consequences to life, relationships, and health. It’s a medical condition involving long-lasting changes in brain reward, stress, and self-control circuits.

While tolerance and dependence are often OUD symptoms, a person can be physically dependent on doctor-prescribed opioids without being addicted.

Overdose

An overdose is a life-threatening medical emergency occurring when someone consumes more opioids than their body can handle, leading to severe central nervous system depression.

The primary cause of death in opioid overdose is respiratory depression—breathing becomes dangerously slow and shallow, or stops altogether. This deprives the brain and vital organs of oxygen, quickly leading to unconsciousness, brain damage, and death.

Critical overdose signs requiring immediate medical intervention (call 911) include:

• Unconsciousness or inability to wake up
• Slow, shallow, or stopped breathing
• Choking or gurgling sounds
• Small, constricted “pinpoint” pupils
• Limp body
• Pale, blue, or cold skin, especially on lips and fingernails

The distinction between physical dependence and addiction is critical. A cancer patient on long-term, medically managed opioid therapy will almost certainly become physically dependent. This is expected. It’s not the same as compulsive, out-of-control drug-seeking behavior defining addiction.

Conflating these terms leads to patient stigmatization and fundamental misunderstanding of OUD as a moral failing rather than a complex brain disease.

The U.S. Opioid Crisis: Three Devastating Waves

The United States has been gripped by a devastating opioid epidemic for over two decades. This public health catastrophe has claimed approximately 806,000 lives from opioid-involved overdoses between 1999 and 2023.

Public health experts at the CDC describe the crisis as unfolding in three distinct but interconnected waves, each defined by the primary opioid type driving overdose deaths.

Wave One: Prescription Opioids (1990s-2010s)

The modern opioid crisis began in the late 1990s with a dramatic surge in opioid pain reliever prescribing. This wasn’t accidental but resulted from converging factors.

Pharmaceutical companies aggressively marketed new opioid formulations, most notably Purdue Pharma’s OxyContin. They promoted these to doctors with claims that addiction risk was very low. Simultaneously, a well-intentioned medical movement advocated for more attentive pain management, even referring to pain as the “fifth vital sign.”

The result was massive opioid prescription increases, which quadrupled nationwide between 1999 and 2010. As millions of Americans were exposed to these powerful drugs, rates of misuse, addiction, and overdose deaths involving prescription opioids like oxycodone and hydrocodone climbed accordingly.

Wave Two: Heroin (Beginning ~2010)

The second wave was a direct, unintended consequence of the response to the first. As prescription opioid death toll mounted, federal agencies and medical organizations implemented stricter controls and more cautious prescribing guidelines.

This successfully reduced legal pill diversion but created new problems for people who had already developed opioid use disorder. As prescription opioid supply tightened and prices rose on the illicit market, many individuals transitioned to a cheaper, more available, more potent alternative: heroin.

Around 2010, an influx of low-cost, high-purity heroin, primarily from Mexico, flooded the U.S. market. Consequently, heroin overdose deaths began skyrocketing, and by 2015, heroin had surpassed prescription opioids as the leading cause of opioid-related overdose fatalities.

Wave Three: Synthetic Opioids (Beginning ~2013)

The third and deadliest wave began around 2013 with illicitly manufactured synthetic opioid proliferation, overwhelmingly dominated by fentanyl and its chemical analogues.

Fentanyl is 50 to 100 times more potent than morphine. Unlike heroin or prescription pills, it can be manufactured cheaply and easily in clandestine labs, primarily in Mexico using chemical precursors sourced from China.

This potent substance quickly saturated the illicit drug supply. A key feature of this wave is deception—fentanyl is often mixed with other drugs like heroin, cocaine, or methamphetamine, or pressed into counterfeit pills resembling legitimate prescriptions.

Many users are unaware they’re consuming this incredibly potent substance, leading to catastrophic overdose death increases. By 2021, synthetic opioids were implicated in 87% of all opioid overdose deaths in the U.S.

The crisis has been further complicated by increasing presence of the veterinary tranquilizer xylazine (“tranq”) mixed into the fentanyl supply. Xylazine doesn’t respond to opioid overdose reversal medications and increases fatal overdose risk.

Crisis by the Numbers

The epidemic scale is staggering. In 2023 alone, approximately 105,000 Americans died from drug overdoses, with nearly 80,000—about 76%—involving an opioid.

This translates to an average of 217 Americans dying from opioid overdose every single day. While provisional 2024 data shows the first significant national decline in overdose deaths in years, the crisis remains a leading cause of death for Americans aged 18-44.

The three waves aren’t isolated events but a tragic, cascading series where market forces and policy interventions in one phase directly set the stage for the next.

Federal Government Response

The U.S. government’s response involves multiple federal agencies, each with distinct missions and tools. The primary agencies are the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA), Substance Abuse and Mental Health Services Administration (SAMHSA), and Centers for Disease Control and Prevention (CDC).

DEA: Law Enforcement and Scheduling

The Drug Enforcement Administration is the lead federal law enforcement agency enforcing the nation’s drug laws under the Controlled Substances Act. Its mission is preventing legal controlled substance diversion into illicit markets while disrupting illegal drug trafficking, ensuring adequate supply for legitimate medical and scientific needs.

A core DEA function under the CSA is drug classification into five “schedules.” This system categorizes substances based on three criteria: accepted medical use, abuse potential, and dependence likelihood.

Schedule I: High abuse potential drugs with no currently accepted medical use. Examples include heroin and LSD.

Schedule II: High abuse potential drugs that can cause severe dependence but have accepted medical applications. Most potent prescription opioids fall here, including fentanyl, oxycodone, hydrocodone, and morphine.

Schedule III: Moderate to low dependence potential drugs. Example: products containing less than 90 milligrams codeine per dose.

Schedule IV: Low abuse and dependence potential drugs. The synthetic opioid tramadol is Schedule IV.

Schedule V: Lowest abuse potential drugs, typically containing limited narcotic quantities for antidiarrheal or antitussive purposes.

This scheduling system dictates everything from manufacturing quotas to prescription requirements.

FDA: Drug Approval and Safety

The Food and Drug Administration protects public health by ensuring human drug safety, efficacy, and security. Its opioid crisis role centers on new medication approval and ongoing safety monitoring once on the market.

The FDA’s initial OxyContin approval in the 1990s included labeling suggesting lower abuse potential due to its controlled-release formulation—a belief later proven wrong. Learning from this, the FDA now employs more stringent post-market safety tools.

One key tool is the Risk Evaluation and Mitigation Strategy (REMS). For all outpatient opioid analgesics, REMS requires drug manufacturers to fund and provide continuing education for healthcare providers on safe prescribing practices and non-opioid alternatives.

Recently, the FDA mandated sweeping changes to opioid pain medication safety labeling. These updates include stronger warnings about addiction and overdose risks with long-term use, removing language implying indefinite use is safe, and adding clear guidance on safely tapering patients off opioids to avoid withdrawal.

SAMHSA and CDC: Public Health Response

While the DEA focuses on enforcement and FDA on drug regulation, SAMHSA and CDC lead the public health response.

SAMHSA’s mission is reducing substance abuse and mental illness impact on America’s communities. The agency spearheads numerous initiatives, including providing federal grant funding to states for treatment access expansion, developing educational toolkits for overdose prevention, and promoting evidence-based recovery practices.

SAMHSA also operates critical public resources like the National Helpline (1-800-662-HELP) and the treatment locator website, FindTreatment.gov.

The CDC acts as the nation’s epidemic data hub. It tracks overdose deaths through its National Vital Statistics System, identifies emerging trends, and publishes crucial data reports and public health guidance.

The CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain was a landmark effort to educate clinicians and curb overprescribing that fueled the crisis’s first wave.

The federal response is fragmented, with inherent tensions between law enforcement (DEA), drug regulation (FDA), and public health (SAMHSA/CDC) missions. The challenge has been coordinating these different arms into a cohesive strategy that simultaneously restricts illicit supply, ensures patient access to legitimate medicine, and expands public health interventions like treatment and harm reduction.

Treatment for Opioid Use Disorder

Opioid Use Disorder is a chronic but treatable medical condition. Decades of research show the most effective OUD treatment approach combines medication with behavioral therapies and counseling. This integrated model provides stability needed for people to begin rebuilding their lives.

Medication-Assisted Treatment: The Gold Standard

Medication-Assisted Treatment (MAT), also known as medications for opioid use disorder (MOUD), is considered the gold standard of care. MAT utilizes FDA-approved medications to address addiction’s neurobiological aspects.

These medications work several ways: they normalize brain chemistry, relieve physiological cravings, alleviate withdrawal symptoms, and block opioid euphoric effects. By stabilizing patients, MAT allows them to cease illicit opioid use and engage more effectively in counseling and other recovery activities.

Three main FDA-approved medications exist for OUD:

Methadone

A long-acting full opioid agonist, methadone slowly activates opioid receptors, preventing withdrawal symptoms and reducing cravings. When taken as prescribed at stable doses, it doesn’t produce the “high” associated with other opioids.

Due to misuse potential, methadone is highly regulated as a Schedule II drug. For OUD treatment, it’s almost exclusively dispensed daily at federally certified Opioid Treatment Programs, often called methadone clinics.

Buprenorphine

A long-acting partial opioid agonist, buprenorphine binds strongly to opioid receptors but activates them only partially. This creates a “ceiling effect”—beyond a certain dose, opioid effects don’t increase, lowering misuse and overdose risk compared to full agonists.

This safety profile allows buprenorphine prescription by doctors, nurse practitioners, and physician assistants with special waivers in office-based settings, greatly increasing treatment accessibility. It’s most often prescribed in combination with naloxone (e.g., Suboxone®), an opioid antagonist added to deter injection misuse.

Naltrexone

An opioid antagonist, naltrexone completely blocks opioid receptors. If someone taking naltrexone uses an opioid, naltrexone prevents the drug from binding to its receptor, blocking any euphoric or sedative effects. This removes reward for opioid use.

Naltrexone is not a narcotic, isn’t addictive, and has no abuse potential. Any licensed healthcare provider can prescribe it. It’s available as daily oral pills or once-monthly extended-release injections (Vivitrol®).

Finding Help: National Resources

Navigating recovery can be daunting. Several confidential, free federal resources are available 24/7 to help individuals and families find treatment and support.

SAMHSA’s National Helpline: Provides treatment referrals and information on substance use and mental health disorders. Call 1-800-662-HELP (4357) or visit SAMHSA’s National Helpline.

FindTreatment.gov: A website to search for substance use and mental health treatment facilities nationwide. Visit FindTreatment.gov.

988 Suicide & Crisis Lifeline: For immediate support for anyone experiencing mental health or substance use-related crisis. Call or text 988 or visit 988lifeline.org.

Safe Use, Storage, and Disposal

While federal agencies work on large-scale solutions, individual citizens play critical roles in preventing opioid misuse and overdose, starting in their homes. Lessons from the first crisis wave, fueled by legally prescribed pill diversion, underscore responsible medication stewardship importance.

Safe Use Guidelines

If you or a loved one is prescribed an opioid, these guidelines can reduce harm risk:

Take medication exactly as prescribed. Don’t increase dose or frequency beyond doctor instructions.

Never mix opioids with other central nervous system depressants. This includes alcohol, benzodiazepines (like Xanax or Valium), and sleeping pills. Combining these substances dramatically increases fatal overdose risk.

Never share your prescription. It’s illegal and extremely dangerous to give medication to someone else, as their tolerance and medical history differ from yours.

Maintain open communication with your doctor. Discuss pain levels, side effects you experience, and medication concerns.

Safe Storage at Home

The majority of people who misuse prescription opioids get them from friends or family, often from home medicine cabinets. Safe storage is crucial prevention strategy.

Prevent access. Keep medications away from children, teenagers, pets, and visitors.

Store them out of sight and reach. At minimum, keep opioids where they cannot be easily seen or accessed.

Lock them up. The most secure method is storing opioids in locked cabinets, locked drawers, or personal medicine lockboxes.

Safe Disposal of Unused Medication

Leaving unused or expired opioids at home creates significant, unnecessary risk of accidental ingestion or intentional misuse. Prompt, proper disposal is essential.

Best Option: Drug Take-Back Programs

The most secure and environmentally responsible disposal method is through authorized drug take-back programs.

DEA National Prescription Drug Take Back Day: The DEA sponsors this event twice yearly in communities nationwide, providing safe, convenient prescription drug disposal.

Year-Round Collection Sites: Many pharmacies, hospitals, and law enforcement agencies host permanent, secure drop boxes for year-round disposal. The DEA provides an online search tool to find authorized collectors at DEA Take Back Day.

At-Home Disposal (If Take-Back Option Unavailable)

If take-back programs aren’t readily accessible, you can dispose of most opioids in household trash by following these steps:

Check the FDA Flush List FIRST: A small number of powerful medications are on the FDA’s “flush list” because they can be especially harmful if accidentally ingested by children or pets. If your medication is on this list, the FDA recommends immediately flushing it down the toilet when no longer needed.

Trash Disposal Method (for non-flush list drugs):

1. Mix: Remove medicine from original container and mix with undesirable substance like dirt, used coffee grounds, or cat litter. This makes the drug less appealing and unrecognizable.
2. Seal: Place mixture into sealable container, such as zippered plastic bag or empty can, preventing leakage.
3. Toss: Throw sealed container into household trash.
4. Scratch Out Info: Protect privacy by scratching out all personal information on the label of empty prescription bottles before recycling or disposal.

Overdose Recognition and Response

Recognizing overdose signs and knowing how to respond can save lives. The primary cause of death in opioid overdose is respiratory depression—breathing becomes dangerously slow and shallow, or stops.

Critical Signs Requiring Immediate Action (Call 911)

• Unconsciousness or inability to wake up
• Slow, shallow, or stopped breathing
• Choking or gurgling sounds
• Small, constricted “pinpoint” pupils
• Limp body
• Pale, blue, or cold skin, especially on lips and fingernails

Naloxone: The Overdose Reversal Drug

Naloxone (Narcan®) is a life-saving medication that can reverse opioid overdose. It’s an opioid antagonist that rapidly displaces opioids from brain receptors, restoring normal breathing and consciousness.

Naloxone is available without prescription at most pharmacies. Many states have Good Samaritan laws protecting people who call for medical help during overdose emergencies from drug possession charges.

The opioid crisis represents one of the most complex public health challenges in American history. Understanding these substances—their medical benefits, inherent risks, and the crisis they’ve created—is essential for developing effective responses that balance legitimate medical needs with public safety concerns.

Recovery is possible. With proper medical treatment, family support, and community resources, people with opioid use disorder can and do recover to lead fulfilling lives.

Our articles make government information more accessible. Please consult a qualified professional for financial, legal, or health advice specific to your circumstances.